DXCM

Q: What is the price of DexCom (DXCM) today?

The price of DexCom (DXCM) today is $ 74.38, with return of -17.27% compared to the last year. The price of DexCom (DXCM) started the year trading around $ 66.37 and today it is at $ 74.38. Follow the real-time price chart, the historical price of DexCom (DXCM) and international markets.

Q: When does DexCom (DXCM) pay dividends?

DexCom (DXCM) did not distribute dividends in the last year.

Q: Is DexCom (DXCM) worth it?

Currently, DexCom (DXCM) is priced at $ 74.38, with a P/E of 33.82%, representing a deviation of 7,924% from its historical average P/E. In the last year, the stock showed a variation of -17.27 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -17.27%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy DexCom (DXCM) stock?

Investing in stocks of DexCom (DXCM) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of DexCom (DXCM) yield today?

The yield of DexCom (DXCM) was 0.96% in the last month, -17.27% in the last year and -25.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of DexCom (DXCM) today, the total investment would be $ 7,438.00, based on the current price of $ 74.38.If past performance were to repeat, the return on your investment would be:In 1 year: $ 6,153.46In 5 years: $ 5,578.50In 10 years: $ 33,708.27It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

DexCom Inc.

Price

$ 74.38

return (12m)

-17.27%

p/e

33.82

p/b

10.30

DIVIDEND YIELD

0.00%

price DXCM

DXCM

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of DXCM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.96%

3 months

17.19%

1 year

-17.27%

2 years

-34.88%

5 years

-25.00%

10 years

353.19%

Fundamentals DXCM

review the fundamentals of DexCom shares

P/E

33.82

Sector: -2.14 Industry: 0.05

P/S (Price-to-Sales)

6.07

Sector: 2.06 Industry: 2.57

P/B

10.30

Sector: 2.34 Industry: 2.50

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

13.19%

Sector: -27.16% Industry: -25.38%

ROE

30.46%

Sector: -30.98% Industry: -31.44%

ROIC

34.06%

Sector: -421.19% Industry: -78.34%

NET MARGIN

17.94%

Sector: -29.07% Industry: -29.80%

GROSS MARGIN

60.10%

Sector: 44.34% Industry: 50.68%

OPERATING MARGIN

19.56%

Sector: -24.62% Industry: -25.92%

EV/EBITDA

22.41

Sector: -0.57 Industry: 1.13

EV/EBIT

26.35

Sector: -2.98 Industry: -1.31

PRICE-TO-ASSETS

4.46

Sector: 1.23 Industry: 1.34

BVPS

7.10

Sector: 3.47 Industry: 4.81

EPS

2.16

Sector: -0.90 Industry: -0.87

EQUITY-TO-ASSETS RATIO

0.43

Sector: 0.42 Industry: 0.44

LIABILITIES / ASSETS

0.57

Sector: 0.46 Industry: 0.51

CAGR REVENUE 5 YEARS

13.75%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

40.14%

Sector: - Industry: -

FAIR VALUE OF DexCom ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 74.38

Fair Value

$ 0.00

Upside Return potential.

-75.03%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals DXCM

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
LLY	43.78	37.88	86.53%	0.59%	$ 903.52 B	31.66%
ISRG	62.65	9.97	15.92%	0.00%	$ 178.94 B	28.38%
TMO	28.66	3.59	12.52%	0.34%	$ 192.11 B	15.05%
SNY	12.51	1.36	10.86%	4.73%	$ 114.14 B	18.68%
NVS	21.85	6.56	30.04%	2.43%	$ 305.57 B	24.67%
ABT	29.61	3.77	12.73%	2.12%	$ 193.15 B	14.72%
MDT	26.07	2.58	9.90%	2.92%	$ 124.17 B	13.71%
GSK	15.56	5.56	35.71%	2.82%	$ 118.68 B	17.48%
CVS	55.09	1.29	2.35%	3.47%	$ 97.40 B	0.44%
BSX	38.16	0.00	0.00%	0.00%	$ 110.60 B	14.44%
TMDX	49.74	12.85	25.84%	0.00%	$ 4.56 B	16.20%
HCA	17.89	-43.80	-244.82%	0.54%	$ 121.36 B	8.97%
IDXX	48.00	31.68	65.99%	0.00%	$ 50.85 B	24.62%
RMD	25.46	5.99	23.51%	0.87%	$ 37.83 B	27.53%
DHR	40.98	2.82	6.88%	0.61%	$ 148.12 B	14.71%
INMD	10.22	1.40	13.73%	0.00%	$ 958.86 M	25.32%
FMS	17.45	0.87	5.00%	3.23%	$ 14.24 B	3.73%
PHG	27.73	2.24	8.06%	2.93%	$ 28.76 B	5.07%
SYK	44.76	6.48	14.48%	0.90%	$ 145.29 B	12.92%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

DXCM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY DexCom

DexCom Inc.

Average user rating I10

4.0 (13 people)

United States

27 years

Founded: 1999

2005

Time since IPO - 21 years

6.400

Employees

The Company DexCom Inc. (United States), is listed on Nasdaq with a market value of $ 28.28 Billions, having an equity of $ 2.75 Billions.

With a total of 6.400 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 4.66 Billions, which generated a profit in the amount of $ 836.30 Millions.

As for its main indicators, the Company has a P/E ratio of 33.82, a P/BV ratio of 10.30 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker DXCM.

Market cap

$ 28.28 Billions

Net worth

$ 2.75 Billions

US$ 2,746,000,000.00

Assets

$ 6.34 Billions

US$ 6,339,900,000.00

Total Shares Outstanding

387.00 Millions

387,000,000

Average Daily Trading Volume

$ 5.49 Millions

US$ 5,485,652.22

Sector

Health

Industry

Medical Supplies and Equipment

DXCM

DXCM revenue and profits

Financial Results DXCM

DRAG THE FRAME TO SEE MORE DATA

DXCM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/B

0.00

CVS - CVS Health

$ 78.01 25,60% (12M)

P/E

55.09

3.47%

ROE

2.35%

P/B

1.29

CI - Cigna

$ 288.82 --2,15% (12M)

P/E

10.85

2.15%

ROE

0.00%

P/B

0.00

CNC - Centene

$ 42.93 --26,22% (12M)

P/E

-3.19

0.00%

ROE

-33.28%

P/B

1.06

HUM - Humana

$ 186.83 --27,20% (12M)

P/E

17.64

1.86%

ROE

6.95%

P/B

1.23

HCA - HCA Healthcare

$ 525.88 65,35% (12M)

P/E

17.89

0.54%

ROE

-244.82%

P/B

-43.80

LLY - Eli Lilly

$ 1,022.02 12,02% (12M)

P/E

43.78

0.59%

ROE

86.53%

P/B

37.88

NVS - Novartis

$ 165.53 60,51% (12M)

P/E

21.85

2.43%

ROE

30.04%

P/B

6.56